药物信息为TAZTIA XTTMbrand of DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP (Watson Pharma, Inc.): DESCRIPTION
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- CONTRAINDICATIONS
- ADVERSE REACTIONS
- OVERDOSAGE
- HOW SUPPLIED
- 外部链接相关的TAZTIA XTTMbrand of DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP (Watson Pharma, Inc.)
Diltiazem hydrochloride is a calcium ion cellular influx inhibitor (slow channel blocker). Chemically, diltiazem hydrochloride is 1,5-benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride, (+)-cis. The structural formula is:

Diltiazem hydrochloride is a white to off-white crystalline powder with a bitter taste. It is soluble in water, methanol and chloroform and has a molecular weight of 450.98. Its molecular formula is C22H26N2O4S•HCl. Diltiazem Hydrochloride Extended- Release Capsules USP (Once-a-Day Dosage) for oral administration, contain diltiazem hydrochloride in extended-release pellets at doses of 120, 180, 240, 300 and 360 mg.
Diltiazem Hydrochloride Extended-release Capsules USP (Once-a-Day Dosage) also contain: black iron oxide, corn starch, ethylcellulose, D&C Yellow #10 Aluminum Lake, FD&C Blue #1 Aluminum Lake, FD&C Blue #2 Aluminum Lake, FD&C Red #40 Aluminum Lake, gelatin, hypromellose 2910, magnesium stearate, nonoxynol 100, pharmaceutical glaze, polysorbate 80, polyacrylic dispersion, povidone, propylene glycol, sucrose, talc and titanium dioxide. The 120 mg capsules also contain: D&C Red #28, FD&C Blue #1 and FD&C Red #40. The 180 mg capsules also contain: D&C Yellow #10, FD&C Blue #1 and FD&C Yellow #6. The 240 mg capsules also contain: D&C Red #28, FD&C Blue #1 and FD&C Red #40. The 300 mg capsules also contain: D&C Red #28, D&C Yellow #10, FD&C Blue #1, FD&C Red #40 and FD&C Yellow #6. The 360 mg capsules also contain: FD&C Blue #1.
For oral administration.
Meets USP requirements for dissolution test 15.
- Drug Information Provided by National Library of Medicine (NLM).
